DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
HEOR, AI, And The Future Of Clinical Trial Technology
ISPOR CEO Rob Abbott on why HEOR must be in the room when clinical trial tech is built, and what ISPOR’s latest Top 10 HEOR Trends Report means for ClinOps.
-
AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
Companies that successfully use AI are those that understand technology magnifies accountability. Anyone that fails to internalize that lesson could find themselves defending the very systems they relied on to bring those products to market.
DCT TECHNOLOGY RESOURCES
-
By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.
-
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
DHT-derived endpoints, especially percentile-based metrics, hold promise for robust, scalable measurement in clinical trials—provided they're chosen statistically and with adherence in mind.
-
Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.
-
DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.
-
Electronic clinical outcome assessments transform the paper-based evaluation into a real-time digital tool that collects insights directly from the patient. Explore how this brings several immediate benefits.
-
Consider these steps when repositioning your clinical data management team to unify cross-functional reviews and align processes and technology to meet the demands of digital trials.